Morning Edition

October 30, 2026

Amino acid arginine restores last-resort antibiotic in mice A Chinese study in mice found that pairing the antibiotic colistin with the amino acid L-arginine killed colistin-resistant E. coli; no human data yet.
Kissht Q2 profit doubles to Rs 125 crore on 45% revenue growth Digital lender Kissht posted Rs 125 crore profit and Rs 732 crore operating revenue for July-September 2026; loan-loss provisions rose only 9%.
Mistral releases Large 4, a 1-trillion-parameter open model France's Mistral released the weights of Large 4, a roughly 1 trillion-parameter model, and says it is the best open model from the West for coding.
Chola Q2 profit rises 41% to Rs 1,630 crore; QIP approved Cholamandalam's July-September profit rose 41% to Rs 1,630 crore as loans grew 25%, and its board cleared a Rs 5,000 crore share sale to institutions.
PNB Housing Q2 profit up 6%; disbursements jump 60% PNB Housing Finance's profit rose 6% to Rs 617 crore in Q2 FY27, with loan disbursements up 60%, bad loans at 0.91% and a CRISIL AAA upgrade.
Pine Labs Q2 profit rises 6.5 times to Rs 39 crore Payments firm Pine Labs reported Rs 806 crore operating revenue and Rs 39 crore net profit for July-September 2026, up from Rs 6 crore a year earlier.
Venttup raises $3 million from Rainmatter and Unicorn India Ventures Bengaluru manufacturing startup Venttup raised a $3 million pre-Series A round led by Zerodha's Rainmatter and Unicorn India Ventures on 29 October 2026.
SEBI makes colour-coded Credit Risk-o-Meter mandatory for bonds SEBI's 7 October 2026 circular requires issuers and online bond platforms to show a colour-coded credit risk meter for debt securities, from about 21 November.
BlackBuck Q2 revenue up 56% to Rs 235 crore; profit 42% higher Truck-tech firm BlackBuck reported Rs 235 crore revenue and Rs 41.4 crore profit for Q2 FY27; its small lending arm made a loss.
Shadowfax Q2 profit jumps 5.2x to Rs 68 crore Logistics startup Shadowfax posted Rs 68 crore profit and Rs 1,538 crore revenue for Q2 FY27, up 57% from a year earlier.
Upcoming: FDA decision due today on Inovio's INO-3107 The FDA's target date to decide on Inovio's DNA therapy INO-3107 for a rare airway disease is 30 October 2026. No outcome has been reported yet.
FDA approves Hibsago, first antisense drug for hepatitis B The FDA approved GSK's Hibsago (bepirovirsen) on 20 October 2026 as an add-on for chronic hepatitis B; about 19% reached functional cure in trials.
Sensex rebounds 905 points as earnings lift markets The Sensex rose 1.24% to 74,151 and the Nifty 1.05% to 22,937 on 29 October 2026 after a weak run, with Brent crude still near $114 a barrel.
RBI sets Rs 14,213 redemption price for 2019-20 gold bonds RBI fixed the early redemption price of Sovereign Gold Bond 2019-20 Series VI at Rs 14,213 a unit for 30 October 2026, based on three days of gold prices.